Derek Archila

Derek Archila

Analyst-Equity at Wells Fargo Securities LLC

Finance
Health Services
Consumer Services

Profile

Derek C.
Archila is a Managing Director & Senior Equity Analyst at Wells Fargo Securities covering Small & Midcap Biotechnology.
He was most recently ranked “runner-up” in the Biotechnology Small & Midcap category in the 2023 Institutional Investor All-America equity research poll.
Previously, Derek was an instrumental part of the II-ranked franchise at Stifel and started his career on the sell-side at Leerink Partners and Oppenheimer & Co. Prior to the sell-side, Derek helped build out the Medtech business at GlobalData and spent 5 years in the Brigham & Women’s Hospital clinical hematology lab.
Derek received a BS in Medical Lab Science and MBA from Northeastern University.

Derek Archila active positions

CompaniesPositionStart
Analyst-Equity 30/09/2021
All active positions of Derek Archila

Former positions of Derek Archila

CompaniesPositionEnd
Analyst-Equity 30/09/2021
Analyst-Equity 30/09/2016
Analyst-Equity -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Derek Archila's experience

Training of Derek Archila

Northeastern University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Derek Archila's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies7

Finance

Health Services

Health Technology

Health Services

Finance

Finance

Finance

See company connections